Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines

Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines

A malaria transmission-blocking vaccine would be a critical tool in achieving malaria elimination and eradication. By using chimpanzee adenovirus serotype 63 and modified vaccinia virus Ankara viral vectored vaccines, we investigated whether incorporating two antigens into one vaccine would result i...

Full description

Bibliographic Details
Main Authors:	Vinay Menon, Melissa C. Kapulu, Iona Taylor, Kerry Jewell, Yuanyuan Li, Fergal Hill, Carole A. Long, Kazutoyo Miura, Sumi Biswas
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-01-01
Series:	Frontiers in Immunology
Subjects:	malaria vaccines dual-antigen transmission-blocking viral-vectors antibodies
Online Access:	http://journal.frontiersin.org/article/10.3389/fimmu.2017.01998/full

Similar Items

Combination of RTS,S and Pfs25-IMX313 Induces a Functional Antibody Response Against Malaria Infection and Transmission in Mice
by: Florian Brod, et al.
Published: (2018-12-01)

Evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria
by: Fan Yang, et al.
Published: (2021-05-01)

A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response
by: Arianna Marini, et al.
Published: (2019-12-01)

Strategies & recent development of transmission-blocking vaccines against Plasmodium falciparum
by: Neha Chaturvedi, et al.
Published: (2016-01-01)

The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate
by: Shwu-Maan Lee, et al.
Published: (2019-11-01)

Evaluating the potential of using urine and saliva specimens for malaria diagnosis in suspected patients in Ghana
by: Enoch Aninagyei, et al.
Published: (2020-09-01)

Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America
by: Myriam Arévalo-Herrera, et al.
Published: (2011-08-01)

Profiling the Targets of Protective CD8+ T Cell Responses to Infection
by: Joseph T. Bruder, et al.
Published: (2017-12-01)

In vitro Multistage Malaria Transmission Blocking Activity of Selected Malaria Box Compounds
by: Malebo HM, et al.
Published: (2020-04-01)

Novel approaches to identify protective malaria vaccine candidates
by: Wan Ni eChia, et al.
Published: (2014-11-01)

Transgenic expression of malaria surface antigens under the control of phaseolin promoter.
Published: (2004)

Genetic studies on antigens of the rodent malaria parasite Plasmodium chabaudi
by: McLean, Ann Paterson
Published: (1986)

Transgenic expression of the malaria surface antigens, MSP142 and MSP119, in plant seeds.
Published: (2004)

Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial
by: Hans de Graaf, et al.
Published: (2021-07-01)

Immunoreactivity of Sera From Low to Moderate Malaria-Endemic Areas Against Plasmodium vivax rPvs48/45 Proteins Produced in Escherichia coli and Chinese Hamster Ovary Systems
by: Myriam Arévalo-Herrera, et al.
Published: (2021-06-01)

Acceptability of a herd immunity-focused, transmission-blocking malaria vaccine in malaria-endemic communities in the Peruvian Amazon: an exploratory study
by: Sara E. White, et al.
Published: (2018-04-01)

Functional Comparison of Blood-Stage Plasmodium falciparum Malaria Vaccine Candidate Antigens
by: Joseph J. Illingworth, et al.
Published: (2019-06-01)

A UK single-centre retrospective analysis of malaria diagnostics
by: Blair Merrick, et al.
Published: (2019-09-01)

A comparative study of regression of jaundice in patients of malaria and acute viral hepatitis
by: D.K. Kochar, K. Kaswan, S.K. Kochar, P. Sirohi, M. Pala, A. Kochar , R.P. Agrawal , A. Das
Published: (2006-09-01)

Malaria and Typhoid Co-infection: Need to Interpret Serological Results Cautiously
by: Monika Matlani, et al.
Published: (2016-02-01)

Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose
by: Wei-Chiao Huang, et al.
Published: (2020-08-01)

Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria – a proposed model-derived age-based regimen for sub-Saharan Africa
by: W. Robert Taylor, et al.
Published: (2018-01-01)

Novel lead structures with both Plasmodium falciparum gametocytocidal and asexual blood stage activity identified from high throughput compound screening
by: Wei Sun, et al.
Published: (2017-04-01)

Malaria parasites: the great escape
by: Laurent Rénia, et al.
Published: (2016-11-01)

Evolution of Host Specificity by Malaria Parasites through Altered Mechanisms Controlling Genome Maintenance
by: Michelle C. Siao, et al.
Published: (2020-03-01)

Immunoserology of malaria
by: Eduardo L. F. Franco
Published: (1986-04-01)

Strong concordance between percent inhibition in oocyst and sporozoite intensities in a Plasmodium falciparum standard membrane-feeding assay
by: Kazutoyo Miura, et al.
Published: (2019-05-01)

Naturally Acquired Antibody Response to Malaria Transmission Blocking Vaccine Candidate Pvs230 Domain 1
by: Bergeline C. Nguemwo Tentokam, et al.
Published: (2019-10-01)

A comparative study of blood smear, QBC and antigen detection for diagnosis of malaria
by: Parija S, et al.
Published: (2009-04-01)

Plasmodium falciparum Merozoite Associated Armadillo Protein (PfMAAP) Is Apically Localized in Free Merozoites and Antibodies Are Associated With Reduced Risk of Malaria
by: Yaw Aniweh, et al.
Published: (2020-04-01)

A discovery and development roadmap for new endectocidal transmission-blocking agents in malaria
by: Jeremy Burrows, et al.
Published: (2018-12-01)

Priming of cytotoxic T cell responses to liver stage malaria parasite antigens
by: Giampietro eCorradin, et al.
Published: (2014-11-01)

New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission
by: Kathleen A. McGuire, et al.
Published: (2017-06-01)

Natural Products: A Potential Source of Malaria Transmission Blocking Drugs?
by: Phanankosi Moyo, et al.
Published: (2020-09-01)

Immunopotentiation by Lymph-Node Targeting of a Malaria Transmission-Blocking Nanovaccine
by: Gregory P. Howard, et al.
Published: (2021-08-01)

Are malaria transmission-blocking vaccines acceptable to high burden communities? Results from a mixed methods study in Bo, Sierra Leone
by: Kaci D. McCoy, et al.
Published: (2021-04-01)

Susceptibility to Plasmodium vivax malaria associated with DARC (Duffy antigen) polymorphisms is influenced by the time of exposure to malaria
by: Flora Satiko Kano, et al.
Published: (2018-09-01)

The antigenic switching network of Plasmodium falciparum and its implications for the immuno-epidemiology of malaria
by: Robert Noble, et al.
Published: (2013-09-01)

Screening for malaria antigen and anti-malarial IgG antibody in forcibly-displaced Myanmar nationals: Cox’s Bazar district, Bangladesh, 2018
by: Austin Lu, et al.
Published: (2020-03-01)

Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus than Sequential Immunization
by: Maria Malm, et al.
Published: (2019-11-01)